Altimmune, Inc. Files 2024 10-K
Ticker: ALT · Form: 10-K · Filed: Feb 27, 2025 · CIK: 1326190
| Field | Detail |
|---|---|
| Company | Altimmune, Inc. (ALT) |
| Form Type | 10-K |
| Filed Date | Feb 27, 2025 |
| Risk Level | medium |
| Sentiment | neutral |
Sentiment: neutral
Topics: 10-K, annual-report, pharmaceuticals
TL;DR
Altimmune filed its 2024 10-K. Financials are in. Check it out.
AI Summary
Altimmune, Inc. filed its 2024 10-K on February 27, 2025, reporting its financial performance for the fiscal year ending December 31, 2024. The company, formerly known as Pharmathene, Inc., is based in Gaithersburg, Maryland. Key financial details and operational highlights for the period are detailed within the filing.
Why It Matters
This filing provides investors and stakeholders with a comprehensive overview of Altimmune's financial health, strategic direction, and potential risks for the fiscal year 2024, influencing investment decisions.
Risk Assessment
Risk Level: medium — As a pharmaceutical company, Altimmune faces inherent risks related to drug development, regulatory approvals, and market competition.
Key Numbers
- 72,352,701 — Total Assets (Reported for the fiscal year ending December 31, 2024.)
Key Players & Entities
- Altimmune, Inc. (company) — Filer of the 10-K
- 2024-12-31 (date) — Fiscal year end
- 2025-02-27 (date) — Filing date
- Pharmathene, Inc. (company) — Former company name
- Gaithersburg, MD (location) — Company headquarters
FAQ
What were Altimmune's total revenues for the fiscal year ending December 31, 2024?
The provided text does not contain specific revenue figures for the fiscal year ending December 31, 2024.
What is Altimmune's primary business segment?
Altimmune, Inc. is classified under the Pharmaceutical Preparations (SIC 2834) industry.
When was Altimmune, Inc. previously known as?
Altimmune, Inc. was formerly known as Pharmathene, Inc. (name change effective October 16, 2007) and Healthcare Acquisition Corp. (name change effective May 5, 2005).
Where is Altimmune, Inc. located?
Altimmune, Inc. is located at 910 Clopper Road, Suite 201S, Gaithersburg, MD 20878.
What is the SEC file number for Altimmune, Inc.'s 10-K filing?
The SEC file number for Altimmune, Inc.'s 10-K filing is 001-32587.
Filing Details
This Form 10-K (Form 10-K) was filed with the SEC on February 27, 2025 regarding Altimmune, Inc. (ALT).